Resources - general public
National Guidelines for Yellow Fever Vaccination Centres and Providers
These guidelines set out the procedure and requirements to become an approved yellow fever vaccination centre.
ATAGI statement on the clinical use of the dengue vaccine Qdenga for Australians
Australian Technical Advisory Group on Immunisation (ATAGI) clinical advice on the dengue vaccine Qdenga.
ATAGI statement on counterfeit rabies vaccines and rabies immunoglobulin: Guidance for travellers and healthcare providers
Australian Technical Advisory Group on Immunisation (ATAGI) advice on counterfeit rabies vaccines and rabies immunoglobulin: Guidance for travellers and healthcare providers
Interim ATAGI advice on the administration of RSV - Specific monoclonal antibodies to Aboriginal and Torres Strait Islander infants and children
Interim Australian Technical Advisory Group on Immunisation (ATAGI) advice on the administration of RSV - Specific monoclonal antibodies to Aboriginal and Torres Strait Islander infants and children
Vaccination dashboards methodology
This page outlines the rules, assumptions and logic that has been applied in developing the four enduring Power BI dashboards.
National Vaccine Storage Guidelines ‘Strive for 5’
The National Vaccine Storage Guidelines ‘Strive for 5’, provides information and advice for vaccine storage management for Australian immunisation service providers.
National Immunisation Program schedule
This schedule provides recommended vaccines and schedule points under the National Immunisation Program.
Influenza (flu) immunisation data – 1 March to 4 October 2026
Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.
ATAGI 124th Meeting Bulletin – 26 August 2026
This document provides an overview of the discussion from the 124th Meeting of the Australian Technical Advisory Group on Immunisation (ATAGI).
National Immunisation Program (NIP) vaccine listing process
The National Immunisation Program (NIP) vaccine listing process sets out the regulatory steps that must occur in order for a vaccine to be supplied through the NIP.
COVID-19 vaccine NIP transition – Consumer fact sheet
This fact sheet provides information about COVID-19 vaccines available on the National Immunisation Program from 1 October 2026.
Policies and procedures for the administration and governance of ATAGI
This document outlines the structure, function, roles and responsibilities of the Australian Technical Advisory Group on Immunisation (ATAGI). The intended audience is ATAGI members and interested members of the general public.
Adult vaccinations brochure
This brochure provides information about recommended vaccines available free for adults under the National Immunisation Program.
Influenza (flu) immunisation data – 1 March to 27 September 2026
Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.
Following vaccination – what to expect and what to do
This resource provides easy-to-read information on common reactions that may occur after vaccinations.
ATAGI statement on the Clinical use of the Dengue vaccine Qdenga for Australians
Australian Technical Advisory Group on Immunisation (ATAGI) advice regarding the Clinical use of QDenga for Australians.
Influenza (flu) immunisation data – 1 March to 13 September 2026
Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.
Influenza (flu) immunisation data – 1 March to 6 September 2026
Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.
ATAGI statement on Transition of COVID-19 Vaccines to the National Immunisation Program
Australian Technical Advisory Group on Immunisation (ATAGI) advice regarding the transition of COVID-19 vaccines to the National Immunisation Program.
COVID-19 NIP transition – Program advice for health professionals
This fact sheet provides advice for vaccination providers about COVID-19 vaccines available on the NIP from 1 October 2026.
COVID-19 vaccine NIP transition – Information kit for health professionals
This information kit is designed to help vaccination providers communicate 1 October 2026 COVID-19 vaccine changes.
Influenza (flu) immunisation data – 1 March to 30 August 2026
Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.
Influenza (flu) immunisation data – 1 March to 24 August 2026
Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.
Influenza (flu) immunisation data – 1 March to 16 August 2026
Weekly report of year to date immunisation figures broken down by age groups and immunising provider types. Compares vaccination rates with the previous 3 years.
National Immunisation Strategy (2025-2030) Implementation Plan
The NISIP is a comprehensive framework for immunisation efforts across the country. It details strategic vision, priorities, governance, roles and specific Commonwealth-led actions to improve vaccine coverage, equity, workforce strength, technology adoption, and governance reform.
Date last updated: